The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
624 - For an HCP targeted APS, are references required in the final layout of the piece after PAAB approval (i.e., a reference list at the end of the piece and superscripts throughout)? Or do references not need to be included in the layout once PAAB has approved the copy doc? Thanks!
-
For HCP targeted advertising, references are required in the final layout of the piece. Yes, as you said, this entails a reference list at the end of the piece and the corresponding superscripts throughout the piece. An alternative is to use the superscripts throughout the piece but include the corresponding reference list in a web location corresponding to a URL presented on the piece. See the PAAB code sections 4.4.3 to 4.4.7.
This is required for adherence to PAAB code section 3.3 (i.e. an HCP would need to know which reference to request from the manufacturer if he/she wanted additional info or wanted to test the evidentiary basis for a claim).
